STI (Solidion Technology, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Solidion Technology, Inc. Common Stock (STI) is a publicly traded Industrials sector company. As of May 21, 2026, STI trades at $4.72 with a market cap of $36.56M and a P/E ratio of -0.44. STI moved +2.18% today. Year to date, STI is -48.64%; over the trailing twelve months it is +38.42%. Its 52-week range spans $2.94 to $55.00. Rallies surfaces STI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns STI stock?
Hedge funds tracked by Rallies that own STI include Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Solidion Technology, Inc. Common Stock.
STI Key Metrics
Key financial metrics for STI
Metric
Value
Price
$4.72
Market Cap
$36.56M
P/E Ratio
-0.44
EPS
$-10.39
Dividend Yield
0.56%
52-Week High
$55.00
52-Week Low
$2.94
Volume
0
Avg Volume
0
Revenue (TTM)
$13.35K
Net Income
$-41.00M
Gross Margin
50.20%
Top Hedge Funds Holding STI
Two Sigma holds 20.13K shares of STI, changed +62.51% as of Dec 31, 2024.
Global Graphene Group, Inc. sold 750 (~$5.90K) on Dec 12, 2025.
Global Graphene Group, Inc. sold 568 (~$4.47K) on Dec 11, 2025.
Global Graphene Group, Inc. sold 3.23K (~$33.52K) on Nov 26, 2025.
STI Analyst Consensus
STI analyst coverage data. Average price target: $0.00.
Common questions about STI
Who owns STI stock?
Hedge funds tracked by Rallies that own STI include Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Solidion Technology, Inc. Common Stock.
Does Rallies show 13F holders for STI?
Yes. Rallies tracks hedge fund and 13F ownership data for STI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is STI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for STI. It does not provide personalized investment advice.